ALLIANCE C80702

Primary Category:

Treatment Protocols

Disease Category:

Colon, Gastrointestinal

Status:

Closed

A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer

 

CALGB/SWOG 80702 is nearing its accrual goal. Therefore, effective Friday, November 20th, 2015 at 4:30 PM ET, CALGB/SWOG 80702 will permanently close to new patient accrual.

NCT#01150045

Leave a Reply